Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenue under licensing agreements		$ 925	$ 0	$ 925	$ 0
Operating expenses:
Research and development expenses		15,744	10,321	29,285	20,604
General and administrative expenses		5,315	2,275	10,553	5,027
Total operating expenses		21,059	12,596	39,838	25,631
Loss from operations		(20,134)	(12,596)	(38,913)	(25,631)
Other income (expense):
Interest income		2,035	743	4,355	1,520
Interest expense		(4)	(3)	(7)	(5)
Other income		144	0	287	0
Other expense		(533)	(4)	(1,135)	(7)
Net loss		$ (18,492)	$ (11,860)	$ (35,413)	$ (24,123)
Per share information
Net income (loss) per share, basic (in dollars per share)	[1]	$ (1.09)	$ (26.68)	$ (2.09)	$ (54.94)
Net income (loss) per share, diluted (in dollars per share)	[1]	$ (1.09)	$ (26.68)	$ (2.09)	$ (54.94)
Weighted-average shares outstanding used in computing net income (loss) per share, basic (in shares)	[1]	16,941,524	444,465	16,922,630	439,073
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in shares)	[1]	16,941,524	444,465	16,922,630	439,073

[1] For the three and six months ended June 30, 2023, net loss per share information is presented for the Company’s then outstanding Class A common stock. For the three and six months ended June 30, 2024, net loss per share information is presented for the Company’s common stock. See Note 1, Reverse Merger and Pre-Closing Financing and Note 3, Net Loss Per Share Attributable to Common Stockholders, for additional information.